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ABSTRACT
Voltage-gated Ca2+ (CaV) channels couple membrane depolarization
toCa2+ influx, triggering a range of Ca2+-dependent cellular processes.
CaV channels are, therefore, crucial in shaping neuronal activity and
function, depending on their individual temporal and spatial properties.
Furthermore, many neurotransmitters and drugs that act through
G protein coupled receptors (GPCRs), modulate neuronal activity by
altering the expression, trafficking, or function of CaV channels. GPCR-
dependent mechanisms that downregulate CaV channel expression
levels are observed in many neurons but are, by comparison, less
studied. Herewe show that the growth hormone secretagogue receptor
type 1a (GHSR), a GPCR, can inhibit the forwarding trafficking of
several CaV subtypes, even in the absence of agonist. This constitutive
form ofGPCR inhibition of CaV channels depends on the presence of a
CaVβ subunit. CaVβ subunits displace CaVα1 subunits from the
endoplasmic reticulum. The actions of GHSR on CaV channels
trafficking suggest a role for this signaling pathway in brain areas that
control food intake, reward, and learning and memory.
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INTRODUCTION
Voltage-gated Ca2+ (CaV) channels are instrumental in coupling a
change in transmembrane voltage to Ca2+ influx that, in turn,
regulates numerous critical neuronal functions. Depending on cell
type, developmental stage and subcellular location, different CaV
subtypes are involved in orchestrating Ca2+-dependent signaling;
CaV1 and CaV2 channels trigger transcription-dependent forms of
synaptic plasticity (CaV1.2 and CaV1.3) (Wheeler et al., 2008) and
fast neurotransmitter release (CaV2.1-3) (Dunlap et al., 1995;
Catterall and Few, 2008; Pan and Zucker, 2009), whereas, CaV3 and
CaV1.3 channels, that activate closer to the resting membrane
potential, are involved in regulating cell excitability and shaping
neuronal firing patterns (Molineux et al., 2006; Perez-Reyes, 2003;
McKay et al., 2006; Xu and Lipscombe, 2001).
The temporal features and spatial distribution of each CaV
channel subtype are strongly related to the specific roles of CaV
channels in different cells (Dolphin, 2012). CaV channels associate
with various proteins and these auxiliary subunits influence their
trafficking to the plasma membrane (Dolphin, 2016; Felix et al.,
2013; Simms and Zamponi, 2012). CaVβ and CaVα2δ are important
auxiliary subunits that promote displacement of CaVα1 subunits
from the endoplasmic reticulum (ER), and influence forward
trafficking as well as stability at the plasma membrane (Felix et al.,
2013; Dolphin, 2012). The influence of auxiliary subunits on CaV3
channels is less clear (Bichet et al., 2000; Fang and Colecraft, 2011;
De Waard et al., 1994). Post-translational modifications, including
asparagine-linked glycosylation, are known to promote cell surface
expression of CaV3.2 (Weiss et al., 2013; Orestes et al., 2013) and
indicate differences between the basic mechanisms controlling the
plasma membrane density of different CaV channel subtypes.
An understanding of the mechanism that control CaV channel
surface density in neurons is essential for a complete view of how
cellular Ca2+ signals are regulated. Studies that explore CaV channel
trafficking have started to contribute to knowledge in this field but
there is much that we still do not know (Marangoudakis et al., 2012;
Erickson et al., 2007). Activated GPCRs can promote CaV channel
removal from the plasma membrane by internalization (Simms and
Zamponi, 2012) and, in some cases, GPCR and CaV channels are
internalized together (Kisilevsky and Zamponi, 2008). Our group
has shown that constitutively active growth hormone secretagogue
receptor type 1a (GHSR), reduces the density of CaV2.1 and CaV2.2
channel currents in both a heterologous expression system and in
hypothalamic neurons (Lopez Soto et al., 2015). Here, we show that
constitutively active GHSR regulates surface expression of several
CaV channel subtypes. We present evidence that GHSR-mediated
reduction in the current of CaV channels depends on the presence of
an auxiliary CaVβ subunit, and functions by downregulating
forward trafficking of CaV channels to the plasma membrane. Our
data reveal a new link between CaVβ subunits and GHSR-dependent
control of CaV channel activity.
RESULTS
We have shown previously that constitutively active GHSR targets
presynaptic CaV2.1 and CaV2.2 in hypothalamic neurons and
reduces their surface density (Lopez Soto et al., 2015). Here, we
investigated whether constitutively active GHSR influences surface
densities of other subtypes of CaV channels. We first assessed
whether GHSR influences the size of CaV1.2 and CaV1.3 channel
current densities. We used whole-cell patch clamp recording with
2 mM Ca2+ as the charge carrier. We recorded CaV channel currents
from tsA201 cells co-transfected with CaV1.2 or CaV1.3, together
with auxiliary subunits CaVα2δ1 and CaVβ3, either with GHSR or an
empty plasmid. Compared to control cells, we found only very small
CaV1.2 and CaV1.3 currents in cells that express GHSR (Fig. 1A),Received 28 June 2017; Accepted 04 October 2017
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but this effect of GHSR was blocked by pre-incubation with the
inverse GHSR agonist SPA (Fig. 1A). This suggests that the
inhibitory actions of GHSR in tsA201 cells depend on constitutive
activity of GHSR. Others have shown that GHSR is expressed at
relatively high levels in hypothalamic neurons (Zigman et al.,
2006). Furthermore, we have shown that constitutively active GHSR
inhibits CaV2.1 and CaV2.2 currents in hypothalamic neurons (Lopez
Soto et al., 2015). We, therefore, tested if GHSR also inhibits
endogenous CaV1 channels in hypothalamic neurons by comparing
CaV1 currents in hypothalamic neuronal cultures derived from wild
type and GHSR-deficient (GHSR-null) mice. Total CaV currents in
neurons isolated from GHSR-null mice were higher than those from
wild type (Lopez Soto et al., 2015). To assess the relative size of CaV1
currents in hypothalamic neurons, in the presence and absence of
GHSR, we used the dihydropyridine agonist Bay K 8644. The use of
Bay K 8644 to induce increase in CaV currents is a robust method to
isolate CaV1 from CaV2 channel currents in neurons (Thomas et al.,
1985; Hess et al., 1984). The augmentation of CaV currents in
response to BayK 8644was twofold greater in GHSR-null neurons as
in those from wild type (Fig. 1B). Therefore, constitutive active
GHSR also inhibits the activity of CaV1 channels.
We next tested if constitutively active GHSR affects CaV3
channel currents. CaV3 channels are functionally and structurally
more distant to CaV1 and CaV2 and, unlike the latter, are not retained
in the ER but traffic to the plasma membrane in the absence of a
CaVβ subunit. Fig. 2 shows that CaV3.2 currents and membrane
surface distribution are unaffected by GHSR coexpression.
CaV3 channels do not require CaVβ subunits to traffic to the
plasma membrane but they do interact with CaVβ and CaVα2δ
subunits when coexpressed in the same cell (Wyatt et al., 1998;
Dolphin et al., 1999; Arias et al., 2005; Dubel et al., 2004). When
we coexpressed GHSR with CaVβ3, GHSR reduces CaV3.2 current
density, and the inhibitory effect of GHSR was blocked by the
inverse agonist SPA (Fig. 3A). In order to visualize CaV3 channels
in living cells, we used GFP-tagged CaV3.2 (CaV3.2-GFP) and
analyzed its surface expression with and without expression of
GHSR.We found reduced levels of CaV3.2-GFP fluorescence at the
cell surface only when GHSRwas coexpressed with CaVβ3, and this
effect of GHSR was blocked by application of SPA (Fig. 3B). By
contrast, CaVα2δ1 did not influence the ability of GHSR to reduce
the density of CaV3 currents (CaV3.2+CaVα2δ1=20.6±4.2 pA/pF
versus CaV3.2+CaVα2δ1+GHSR=12.1±2.9 pA/pF, n=5 and 7,
P=0.11). Our results suggest that the CaVβ auxiliary subunit is
necessary to reconstitute the inhibitory effect constitutively active
GHSR has on CaV3 currents.
We next tested if the inhibitory effects of constitutively active
GHSR on CaV2 channels also depend on the presence of CaVβ
subunits. In the absence of CaVβ, CaV2.2 currents were small but
measurable, and coexpression of GHSR did not have an effect on
CaV2.2 current levels (Fig. 4A). This result is in contrast to control
conditions under which GHSR reduces CaV2.2 current density in
cells that also express CaVβ and CaVα2δ (Fig. 4B). In addition, we
found no differences in CaV2.2-GFP plasma membrane signal in
cells expressing GHSR in the absence of CaVβ when compared to
control cells (Fig. 4C, top and bottom panels, respectively). We also
tried to record CaV2.2 currents in cells in the absence of CaVα2δ but
wewere unable to detect CaV2.2 currents above baseline (3.33±1.50
pA/pF, n=5, P=0.091). However, we did observe a plasma
Fig. 1. GHSR constitutive activity reduces CaV1.2 and CaV1.3
currents in tsA201 cells, and reduces native CaV1 currents in
cultured hypothalamic neurons. (A) Representative CaV current
traces from tsA201 cells co-transfected with CaV1.2, CaVα1δ2,
CaVβ3 and GHSR (+GHSR, n=8) or from controls transfected with
empty plasmid (-GHSR, n=12), and average ICa for each condition
(left). Representative CaV current traces from tsA201 cells
co-transfected with CaV1.3, CaVα1δ2, CaVβ3 and GHSR (+GHSR,
n=13) pre-incubated or not with SPA 1 µM (+SPA, n=9) and from
controls transfected with empty plasmid (-GHSR, n=19), and
average ICa for each condition (right). (B) Representative traces of
the Bay K 8644 (BayK) effect (5 µM) on the Ba2+ current from
GHSR-deficient (GHSR null, n=5) and wild-type (Wild type, n=7)
hypothalamic neurons (left), and average IBa increase (right). Error
bars represent mean±s.e.m., individual points represents current
registered (A) or current increase for each cell (B). Kruskal–Wallis
with Dunn’s post-test (CaV1.3), Mann–Whitney test (CaV1.2) (A),
and Student’s t-test (B).
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membrane CaV2.2-GFP signal in cells not expressing CaVα2δ
(Fig. 4C, middle panel) and this signal was reduced by GHSR
coexpression by an amount that was similar to the reduction
observed in cells expressing GHSR, CaV2.2, CaVβ and CaVα2δ
(Fig. 4C, bottom panel). Our results suggest that CaVβ, but not
CaVα2δ, is required for the inhibitory actions of constitutively active
GHSR on CaV channels, and that the actions of GHSR involve
reduced expression of CaV2.2 at the plasma membrane.
The effects of GHSR on CaV current density might involve
impaired forward trafficking from the ER and Golgi and/or
enhanced internalization from the plasma membrane to recycling
endosomes (RE) (Simms and Zamponi, 2012). To distinguish
Fig. 2. GHSR constitutive activity fails to reduce CaV3.2 density on the plasmamembrane. (A) Representative CaV current traces (left) from tsA201 cells co-
transfected with CaV3.2 and GHSR (+GHSR, n=10) or empty plasmid (-GHSR, n=15), and average ICa for each condition (right). (B) Photomicrographs (left)
and average of GFP plasma membrane signal (in percent) (right) of tsA201 cells co-transfected with CaV3.2-GFP and GHSR (+GHSR, n=88) and from
controls transfected with empty plasmid (-GHSR, n=94). Green and red signals correspond to the eGFP tag on CaV3.2 and the CellMask membrane marker,
respectively. Scale bar: 10 µm. Error bars represent mean±s.e.m., individual points represent each cell analyzed.
Fig. 3. GHSR constitutive activity reduces CaV3.2 density on plasma membrane and, consequently, the CaV3.2 current in a CaVβ3-dependent manner.
(A) Representative CaV current traces (left) from tsA201 cells co-transfected with CaV3.2, CaVβ3 and GHSR (+GHSR) pre-incubated or not with SPA 1 µM
(+GHSR+SPA), and from controls transfected with empty plasmid (-GHSR) and average ICa in presence of increasing CaVβ3/CaV3.2 molar ratios (right).
(B) Photomicrographs (left) and average of GFP plasma membrane signal (in percent) (right) of tsA201 cells co-transfected with CaV3.2-GFP, CaVβ3 and GHSR
(+GHSR, n=21) pre-incubated or not with SPA 1 µM (+GHSR+SPA, n=14) and from controls transfected with empty plasmid (-GHSR, n=27). Green and red
signals correspond to the eGFP tag on CaV3.2 and the membrane marker CellMask, respectively. Scale bar: 10 µm. Dots represent mean±s.e.m., numbers
in brackets represent the number of analyzed cells in A. Error bars represent mean±s.e.m. and individual points represent each cell analyzed in B. Mann–Whitney
test and Kruskal–Wallis with Dunn’s post-test (A). Kruskal–Wallis with Dunn’s post hoc test (B).
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between these possibilities, we analyzed the subcellular localization
of CaV channels in the presence or absence of GHSR. We used
eGFP-tagged CaVβ3 and CaVβ2a (CaVβ3-eGFP and CaVβ2a-eGFP,
respectively), as well as genetically encoded plasmamembrane, ER,
Golgi and RE markers to study CaV2.2 channels distribution among
these different compartments in tsA201 cells. We know that the
inhibitory effects of GHSR on CaV2.2 are observed in cells that
express either the CaVβ3 or the CaVβ2a subtype (Lopez Soto et al.,
2015). CaVβ2a can be palmitoylated and this modification increases
its interaction with the plasma membrane (Chien et al., 1995; Chien
et al., 1996; Chien et al., 1998), whereas CaVβ3 is a soluble protein
and only migrates to the plasma membrane when in complex with
CaVα1 (Bichet et al., 2000). Consistent with our functional studies,
we observed a reduced CaVβ2a-eGFP signal at the plasma
membrane when GHSR is coexpressed and this effect was
blocked by SPA pre-incubation (Fig. 5A). We also found a
concomitant increase in the CaVβ2a-eGFP signal at the ER,
accompanied by a mild decrease in the proportional amount of
CaVβ2a-eGFP located at Golgi complex. Under these conditions, the
CaVβ2a-eGFP signal in recycling endosomes was unchanged across
different experimental conditions (Fig. 5B). We also assayed
changes in the distribution CaVβ3-eGFP that were due to the
presence of GHSR and found they were similar to the distribution of
CaVβ2a-GFP (Fig. 6). In agreement with this result, we found that
dominant-negative version of Rab11b, a protein that controls
internalization of CaV1.2 to endosomes, does not alter the reduction
of the CaV current density caused by GHSR [CaV2.2
+CaVα1δ2+CaVβ3+Rab11bGDP=7.4±1.7 pA/pF (n=10) versus
CaV2.2+CaVα1δ2+CaVβ3+Rab11bGDP+GHSR=0.0±0.0 pA/pF
(n=4), P=0.0208]. We also found a similar result when assaying
the small GTPase RhoA. This protein is involved in modifying the
surface densities of CaV2.1, CaV2.2 and CaV2.3 by promoting an
internalization-dependent mechanism (Rousset et al., 2015); and we
did not find an effect of a RhoA inhibitor (C3 toxin) on reduction of
CaV2.2 currents caused by GHSR [CaV2.2+CaVα1δ2+CaVβ3+
C3=19.6±3.6 pA/pF (n=4) versus CaV2.2+CaVα1δ2+CaVβ3+C3
+GHSR=0.0±0.0 pA/pF (n=4), P=0.0017].
Next we asked if GHSR can modify the subcellular location of
CaVβ subunits independently of the CaV channel, by repeating the
above experimental series in the absence of CaVα1. Under these
conditions, without CaV2.2, GHSR coexpression failed to modify
the distribution of CaVβ3 and CaVβ2a. As reported by others (Bichet
et al., 2000), CaVβ3 alone does not traffic to the plasma membrane
(Fig. 7). We also tested if the CaVα1 and CaVβ interaction is required
for the inhibitory effect of constitutive active GHSR.We assayed the
Trp391Ala mutant of CaV2.2 mutant (CaV2.2W391A) that has
Fig. 4. Presence of CaVβ3 but not that of CaVα2δ1 is required for GHSR constitutive activity to reduce CaV2.2 current by decreasing CaV2.2 density on
plasma membrane. (A) Representative CaV currents from tsA201 cells co-transfected with CaV2.2, CaVα2δ1 and GHSR (+GHSR, n=44) or from controls
transfected with empty plasmid (-GHSR, n=51) and average ICa for each condition. (B) Representative CaV currents from tsA201 cells co-transfected with
CaV2.2, CaVβ3, CaVα2δ1 andGHSR (+GHSR, n=22) or empty plasmid (-GHSR, 48) and average ICa for each condition. (C) Photomicrographs and averagedGFP
plasma membrane signal (in percent) of tsA201 cells co-transfected with CaV2.2-GFP, CaVα2δ1 and GHSR (+GHSR, n=87) and from controls transfected with
empty plasmid (-GHSR, n=135) (top). Photomicrographs and average of GFP plasma membrane signal (in percent) of tsA201 cells co-transfected with CaV2.2-
GFP, CaVβ3 and GHSR (+GHSR, n=51) or from controls transfected with empty plasmid (-GHSR, n=42) (middle). Photomicrographs and average of GFP plasma
membrane signal (in percent) of tsA201 cells co-transfectedwith CaV2.2-GFP, CaVβ3, CaVα2δ1 andGHSR (+GHSR, n=29) or from controls transfectedwith empty
plasmid (-GHSR, n=27) (bottom). Green and red signals correspond to the eGFP tag on CaV2.2 and the membrane marker CellMask, respectively. Scale bars:
10 µm. Error bars represent mean±s.e.m. and individual points represent each cell analyzed. Mann–Whitney test.
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impaired affinity for CaVβ (Van Petegem et al., 2008; Leroy et al.,
2005). As shown in Fig. 8A, this mutant failed to block the GHSR
inhibitory effect when CaVβ3 or CaVβ2a were present. Moreover, we
also assayed a C-terminally truncated form of CaVβ2a (CaVβ2aTF8n)
that has been reported to fail to increase CaV2.1 currents and to
change activation parameters (Leyris et al., 2009), suggesting it is
unable to interact with the CaVα1 subunit. As we show in Fig. 8B,
GHSR impairs the CaV2.2 current in the presence of CaVβ2aTF8n.
Taking together, these experiments indicate that a Trp391Ala
change in CaVα1 or truncation of CaVβ are not sufficient to block the
inhibitory effect of GHSR.
Our data indicate that constitutively active GHSR interferes with
the surface expression of CaV1, CaV2 and CaV3 channels by
promoting the retention of CaVα1 subunits in the ER when CaVβ
subunits are present.
DISCUSSION
GHSR is crucially important in the regulation of appetite and
bodyweight, and in learning and memory. Here, we extend previous
studies of the effect constitutively active GHSR exerts on CaV2
channels, and show that GHSR also downregulates the activity of
CaV1 and CaV3 channels. GHSR prevents CaV channels from
leaving the ER, but only when CaVβ subunits are present, resulting
in reduced density of surface channel.
GPCR-dependent regulation of neuronal CaV channels alter
receptor and channel trafficking in many cases, including that of
the mu 1 opioid receptor (OPRM1), opioid-receptor receptor-like 1
(ORL1, also known as OPRL1), dopamine receptors (DRDs) and
γ-aminobutyric acid (GABA) type B receptor subunits (GABBR1
and GABBR2). This form of modulation is long lasting and
independent of neuronal activity (Gray et al., 2007). Several of
these receptors reduce the surface density of CaV channels by
internalizing the channel or co-internalizing a GPCR–channel
complex. ORL1 reduces CaV channel density at the plasma
membrane after long exposures to the agonist, and this process
implicates increasing trafficking to early endosomes or to lysosomes
(Altier et al., 2006). Removal of channels from the surface is unlikely
to participate in the constitutively active GHSR mechanism since we
failed to observe any increase of channel complexes on the recycling
endosome. However, as we report for GHSR, other GPCRs can
regulate CaV channel activity and surface density in the absence of
agonist. For instance, ORL1 exerts a negative modulation of CaV2.2
channel activity in absence of nociceptin, by forming a complex
between itself and the CaV2.2 channel (Beedle et al., 2004).
Fig. 5. GHSR constitutive activity reduces CaVβ2a density on the plasmamembranewhile increasing it on the ER. (A) Confocal images of tsA201 cells co-
transfected with CaV2.2, CaVβ2a-eGFP, CaVα2δ1, plasmamembrane marker (PM-marker), endoplasmic reticulum-marker (ER-marker) and GHSR pre-incubated
with SPA (1 µM) (+GHSR+SPA, n=18) or not (+GHSR, n=18) and controls expressing empty plasmid (-GHSR, n=19). (B) Confocal images of tsA201
cells co-transfected with CaV2.2, CaVβ2a-eGFP, CaVα2δ1, Golgi complex marker (Golgi-marker), recycling endosome marker (RE-marker) and GHSR pre-
incubated with SPA (1 µM) (+GHSR+SPA, n=15) or not (+GHSR, n=20) and controls expressing empty plasmid (-GHSR, n=16). Bar graphs show the
colocalization of green signal from CaVβ2a-eGFP with blue signal (from PM-marker or Golgi-marker) or with red signal (from ER-marker or RE-marker). Error bars
represent mean±s.e.m. and individual points represent each quantified cell. Scale bars: 10 µm. Oneway-ANOVAwith Tukey’s post hoc test (F2, 52=10.28) (A) and
Kruskal–Wallis with Dunn’s post-test (B).
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Moreover, DRD1 and DRD2 interact directly with CaV2.2 to increase
channel surface expression levels under basal conditions, whereas
agonist-activated DRD1 and DRD2 internalize together with CaV
channels (Kisilevsky and Zamponi, 2008; Kisilevsky et al., 2008).
These reports have shown that GPCRs are able to impact on channel
trafficking by directly interacting with the channel itself. In the case
of GHSR, we know that the effect depends on the degree of GHSR
gene expression (Lopez Soto et al., 2015), which opens the
possibility that chronic inhibition of CaV trafficking needs direct
interaction of GPCR and the CaV channel.
We have shown here that constitutive active GHSR reduces
forward trafficking of CaV channels only when the CaVβ subunit is
present. Indeed, the ratio of CaVβ to CaVα1 influences how much
CaV3 currents are downregulated by GHSR. As this effect depends
on the stoichiometry of channel subunits, we suggest that the
interaction of channels subunits is needed such that GHSR is able to
exert its inhibitory effect. Consistent with this, we found that CaVα1
must be present for GHSR to modify the subcellular localization of
eGFP-tagged CaVβ. However, we also found that the inhibitory
effect of GHSR was not changed by CaV2.2W391A or
CaVβ2aTF8n. These results suggest that the interaction between
CaVα1 and CaVβ, mediated by W391 in the α-interaction domain
(AID) and/or the segment lacking in CaVβ2aTF8n, is not required for
the GHSR inhibitory effect. More experiments are, therefore,
required to conclude whether the presence of CaVβ alone is
sufficient to mediate the inhibitory effect of GHSR.
Considering that the chronic inhibition of CaV channels by GHSR
relies on retention of CaV channels at the ER − during which we
observed a mild decrease in the proportional amount of channels
located at Golgi complex (CaVβ2a only) −we postulate that CaVβ acts
as an inhibitor for forward traffickingwhenGHSR is active in addition
to its established stimulatory role. In this regard, previous studies have
shown that CaVβ controls forward trafficking of CaV channels (Simms
and Zamponi, 2012) by preventing channel ubiquitylation and
posterior degradation through the proteasome, by masking a
putative ER-retention domain (Altier et al., 2011; Fang and
Colecraft, 2011). However, several reports suggest a dual function
of CaVβ, as (1) stimulator of forward trafficking and (2) mediator of
trafficking to endosomes. Hidalgo’s group has postulated a
mechanism in which small GTPases and dynamin simultaneously
interact with CaVβ dimers and, as a consequence, stimulate the
endocytosis of channel complexes (Gonzalez-Gutierrez et al., 2007;
Miranda-Laferte et al., 2011). We found that two different small
GTPases, Rab11b and RhoA, are not involved in the mechanism that
Fig. 6. GHSR constitutive activity reduces CaVβ3 density on the plasmamembrane while increasing it on the ER. (A) Confocal images of tsA201 cells co-
transfected with CaV2.2, CaVβ3-eGFP, CaVα2δ1, plasma membrane marker (PM-marker), endoplasmic reticulum-marker (ER-marker) and GHSR pre-incubated
with SPA (1 µM) (+GHSR+SPA, n=14) or not (+GHSR, n=21) and of controls transfected with empty plasmid (-GHSR, n=25). (B) Confocal images of tsA201
cells co-transfected with CaV2.2, CaVβ3-eGFP, CaVα2δ1, Golgi marker (Golgi-marker), recycling endosome marker (RE-marker) and GHSR pre-incubated
with SPA (1 µM) (+GHSR+SPA, n=16) or not (+GHSR, n=16) and of controls transfected with empty plasmid (-GHSR, n=7). Bar graphs show the colocalization of
green signal from CaVβ3-eGFP with blue signal (from PM-marker or Golgi-marker) or with red signal (from ER-marker or RE-marker). Scale bars:10 µm. Error
bars represent mean±s.e.m., individual points represent each quantified cell. One way-ANOVA with Turkey’s post-test (F2, 57=16.43) (CaVβ3-eGFP/PM-marker
overlap) and Kruskal–Wallis with Dunn’s post-test.
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underlie GHSR basal inhibition of CaV, supporting the idea that an
internalization process is unlikely to mediate this effect. If CaV
channels are retained in intracellular compartments, an open
question is what happens to them. There are several reports
demonstrating that reduced CaV trafficking is followed by
increased channel degradation through the proteasome (Waithe
et al., 2011; Marangoudakis et al., 2012; Altier et al., 2011).
Interestingly, it has been shown that CaVβ is necessary for the
increase of NeDD4-1-mediated CaV channel degradation through
proteasomes and lysosomes (Rougier et al., 2011). One key
difference between the findings described by Rougier et al. and us
is that, according to Rougier and colleagues, CaV3 channels are not
affected by NeDD4-1 (officially known as NEDD4) − even in
presence of CaVβ, indicating that distinct mechanisms are involved
in both processes. More research is needed to conclude which
molecular players execute the effect of GHSR basal activation on
CaV trafficking.
We have shown previously that constitutively active GHSR
reduces the surface density of CaV2 channels (Lopez Soto et al.,
2015). Here, we extended our study to other CaV channel subtypes
to show that this chronic basal inhibition by GHSR is common to all
CaV subtypes, including neuronal CaV1 currents. CaV1 channels
control Ca2+-modulated transcription by coupling voltage changes
to Ca2+ influx at dendrites and soma of neurons (Dolmetsch et al.,
2001; West et al., 2001). The best-studied effect of GPCR activity
on CaV1 is the enhanced activity through acute activation of GPCRs
that are coupled to Gs proteins (Olson et al., 2005). In our case, the
number of CaV1 channels is chronically reduced − an effect that
would compete with Ca2+ release from internal compartments that
has been described in response to GHSR activation in neurons
(Cabral et al., 2012; Cowley et al., 2003; Andrews et al., 2009) −
indicating that GHSR exert a fine control of Ca2+ dynamics and,
consequently, Ca2+-dependent gene activation in neurons.
We also demonstrated that GHSR inhibits CaV3.2 currents. In
neurons, CaV3 channels control the shape and frequency of action
potentials (Perez-Reyes, 2003; Zhang et al., 2013), and changes in
channel activity due to alternative splicing (Murbartian et al., 2004;
Latour et al., 2004) or nonsense mutations (Powell et al., 2009) are
responsible for pathophysiological states, such as epilepsy (Hamed,
2008). Yet, the mechanisms that control CaV3 trafficking and surface
membrane stability are largely unknown (Zhang et al., 2013). What is
known, however, is that hormonal changes during epilepsy can alter
the surface expression of CaV3.1 (Qiu et al., 2006). Our current data
suggest that neurons that express GHSR at high levels negatively
modulate the participation of CaV3 in waveform and frequency of
action potentials. A crucial finding is that the presence of CaVβ is
mandatory forGHSR-mediated negativemodulationofCaV3 currents.
In this regard, the interaction between CaVβ and CaV3 is not clearly
established. Some reports that support this interaction have shown that
CaV3 currents are enhanced following coexpression of CaVβ (Dolphin
et al., 1999; Dubel et al., 2004; Dolphin, 2003). By contrast other
studies have failed to demonstrate a direct impact of CaVβ on CaV3
current levels (Leuranguer et al., 1998; Bae et al., 2010). Our data
indicate for the first time that CaVβ is required for impairment of
CaV3.2 trafficking mediated by constitutive active GPCR, thereby
uncovering a new inhibitory function of CaVβ on CaV3 currents.
GHSRs arewidely expressed in the brain (Zigman et al., 2006;Mani
et al., 2014). On the basis of our current and previous data; we propose
that this receptor controls CaV density in neurons. Moreover, we
propose that impairment of CaV trafficking byGHSRcan be overcome
Fig. 7. GHSR constitutive activity fails to reduce CaVβ density on plasma membrane in the absence of CaVα1. (A) Confocal images of tsA201 cells co-
transfected with CaVβ2a-eGFP, CaVα2δ1, plasma membrane marker (PM-marker), endoplasmic reticulum-marker (ER-marker) and GHSR (+GHSR, n=9) or of
controls transfected with empty plasmid (-GHSR, n=9). (B) Confocal images of tsA201 cells co-transfected with CaVβ3-eGFP, CaVα2δ1, plasmamembranemarker
(PM-marker), endoplasmic reticulum-marker (ER-marker) and GHSR (+GHSR, n=7) or of controls transfected with empty plasmid (-GHSR, n=8). Bar graphs
show the colocalization of green signal from CaVβ3-eGFP or CaVβ2a-eGFP with blue signal (from PM-marker) or with red signal (from ER-marker). Scale bars:
10 µm. Error bars represent mean±s.e.m., individual points represent each quantified cell. Student’s t-test (A) and Mann–Whitney test (B).
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by activation of other GPCRs that counteract the signaling cascade of
constitutively active GHSRs. This would lead to a time- and place-
specific fine-tuning of CaV membrane insertion. Since each neuronal
CaV channel subtype has fundamental functions, constitutively active
GHSRs would have great impact on the activity of GHSR-expressing
neurons. This new form of neuronal activity modulation might,
therefore, be relevant in the regulation of neuronal excitability, synaptic
plasticity and neurotransmitter release that depends on channel
complexes t formed with CaVβ in GHSR-expressing neurons.
MATERIALS AND METHODS
Cell culture and transient transfection
tsA201 cells were grown in Dulbecco’s modified Eagle’s medium (DMEM;
Gibco) with 10% fetal bovine serum (FBS; Internegocios) and subcultured
when 80% confluent. For patch-clamp experiments, tsA201 cells were
co-transfected with plasmids containing GHSR (GHSR, GenBank
accession no. AY429112) and voltage-gated Ca2+ channel subunits
CaV1.2 (Cacna1c, GenBank accession no. AY728090), or CaV1.3-GFP
(Cacna1d, GenBank accession no. AF370009), or CaV2.2 (Cacna1b,
GenBank accession no. AF055477) or CaV3.2-GFP (Cacna1 h, GenBank
accession no. NM021098) with or without auxiliary subunits CaVβ3
(Cacnb3, GenBank accession no. M88751) and CaVα2δ1 (Cacna2d1,
GenBank accession no. AF286488), using Lipofectamine 2000
(Invitrogen). Some experiments were performed using different mutants,
such as CaV2.2W391A (Addgene no. 58734) (Leroy et al., 2005) or
CaVβ2aTF8n (Leyris et al., 2009). For some experiments, which lacked one
or more plasmids, cells were transfected with empty plasmid pcDNA3.1 (+)
to maintain the total cDNA amount in the transfection mix and eGFP-
containing plasmid to identify the cells transfected. Other clones used in this
paper were Rab11bS25N (Rab11bGDP) and pCDNA3-C3-toxin (C3-
toxin). For live imaging experiments green fluorescent protein (GFP)-
tagged CaV2.2 (CaV2.2-GFP) was used. For confocal imaging experiments,
enhanced
(e)GFP-tagged-auxiliary subunits CaVβ (CaVβ2a-eGFP, Cacnb2, GenBank
accession no. M80545 and CaVβ3-eGFP, Cacnb3, GenBank accession no.
M88751), and plasmids that encode for different intracellular compartments
markers: pPalmitoyl-mTurquoise2 (plasma membrane marker, Addgene
no. 36209), mCh-Sec61β (ER marker, Addgene catalog no. 49155),
pmTurquoise2-Golgi (Golgi marker, Addgene catalog no. 36205) and
DsRed-Rab11WT (recycling endosome marker, Addgene catalog no.
12679) were used. After transfection, cells were kept in culture to allow
the expression of Ca2+ channels for 24-48 h, depending on the CaV channel
subtype. Then, cells were dispersed with 0.25 mg/ml trypsin, rinsed twice
and kept at room temperature (23°C) in DMEM during the patch-clamp
experimental day.
Clones of Ca2+ channel subunits (except CaV3.2-GFP and CaV2.2-GFP)
were generated in D.L.’s lab. CaV3.2-GFP clone was a gift from
Dr E. Bourinet (Institut de Génomique Fonctionnelle, Université de
Montpellier, France). CaV2.2-GFP clone was provided by Dr G. W.
Zamponi (Department of Physiology and Pharmacology, University of
Calgary, Canada). Auxiliary subunits CaVβ2a-eGFP and CaVβ3-eGFP were a
gift from Dr Byung Chang Suh (Department of Brain Science, Daegu
Gyeongbuk Institute of Science and Technology, South Korea). The GHSR
clone was provided by Dr J. Marie (Université de Montpellier, Montpellier,
France). The CaVβ2aTF8n clone was a gift from Dr P. Charnet (CRBM,
CNRS, Université de Montpellier, France), the Rab11bS25N (Rab11bGDP)
clone was provided by Dr M. V. Khvotchev (Department of Neurology,
University of California, San Francisco, CA) and the pCDNA3-C3-toxin
clone was provided by Dr C. Davio (University of Buenos Aires, Argentina).
Drugs
For patch-clamp and imaging experiments on tsA201 cells, the inverse GHSR
agonist, [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-substance P (SPA; Santa Cruz
Biotechnology, Inc.) was used. For patch-clamp on mouse neuronal primary
culture CaV1 agonist Bay K 8644 (Sigma-Aldrich) was used.
Animals
Wild type and GHSR1a-deficient (GHSR-null) mice (3–5-month-old
females) were bred at the IMBICE animal facility. Wild-type mice, on a
pure C57BL/6 background. GHSR-null mice, which fail to express
GHSR1a, were derived from crosses between heterozygous animals that
had been back-crossed >10 generations onto a C57BL/6 genetic
background. All animals were housed in a 12 h light–dark cycle in a
climate-controlled room (22°C) with ad libitum access to water and food.
This study was performed in strict accordance with the recommendations of
the Guide for the Care and Use of Laboratory Animals of the National
Research Council and all efforts were made to minimize animal suffering.
All experimentation received approval from the Institutional Animal Care
and Use Committee of the IMBICE (ID:10-0112).
Mouse primary neuron culture
Neuron cultures were obtained from GHSR-null mice at embryonic days
16–18. The protocol used was similar to the one described by Raingo et al.
Fig. 8. AW391A mutation of CaVα1 or truncation of CaVβ are not
sufficient to block the inhibitory effect of GHSR on CaV2.2 activity.
(A) Representative CaV current traces from tsA201 cells co-transfected with
CaV2.2W391A, CaVα1δ2, CaVβ3 and GHSR (+GHSR, n=7) or from controls
transfected with empty plasmid (-GHSR, n=7), and average ICa for each
condition (top). Representative CaV current traces from tsA201 cells co-
transfected with CaV2.2W391A, CaVα1δ2, CaVβ2a and GHSR (+GHSR, n=5) or
from controls transfected with empty plasmid (-GHSR, n=8), and average ICa
for each condition (bottom). Error bars represent mean±s.e.m., individual
points represents current registered. Student’s t-test (top) and Mann–Whitney
test (bottom). (B) Representative CaV current traces from tsA201 cells co-
transfected with CaV2.2, CaVα1δ2, CaVβ2aTF8n and GHSR (+GHSR, n=10) or
from controls transfected with empty plasmid (-GHSR, n=14), and average ICa
for each condition. Error bars represent mean±s.e.m., individual points
represents current registered. Mann–Whitney test.
3914
RESEARCH ARTICLE Journal of Cell Science (2017) 130, 3907-3917 doi:10.1242/jcs.207886
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
(2012). In brief, the necks of pregnant mice were dislocated and embryos
quickly removed. The brain of the embryo was exposed, placed on its dorsal
side and the the hypothalamus was removed with forceps. Brains were
placed in sterile Hank’s solution and rinsed twice. Then, cells were
dissociated at 37°C for 20 min with 0.25 mg/ml trypsin (Microvet). Enzyme
digestion was stopped by addition of 300 µl FBS, and 0.28 mg/ml
deoxyribonuclease I from bovine pancreas (Sigma-Aldrich) was added.
Cells were mechanically dissociated using several glass pipettes with
consecutive smaller-tip diameters. We plated about 50,000 cells on 12-mm
diameter glass coverslips that had previously been treated with poly-L-
lysine (Sigma-Aldrich) and were laid over 24-well plates. We incubated
cells at 37°C in a 95% air and 5% CO2 atmosphere with DMEM (Microvet)/
F12 (1:1), supplemented with B27 (1:50, Gibco), 10% FBS, 0.25% glucose,
2 mM glutamine (Gibco), 3.3 µg/ml insulin (Novo Nordisk Pharmaceutical
Industries, Inc.), 40 µg/ml gentamicin sulfate (Richet) and a 1% vitamin
solution (Microvet). At day 4 of culture, half of the medium was replaced by
fresh medium containing cytosine β-d-arabinofuranoside (Sigma-Aldrich)
to reach a final concentration of 5 µM.
Electrophysiology
Ion channel currents were recorded by using an Axopatch 200 amplifier
(Molecular Devices). Data were sampled at 20 kHz and filtered at 10 kHz
(−3 dB) using PCLAMP8.2 software (Molecular Devices). Recording
electrodes with resistances between 2 and 4 MΩ were used and filled with
internal solution. Series resistances of <6MΩwere admitted and compensated
to 80%with a 10 µs lag time. Current leak was subtracted on-line using a P/−4
protocol. All recordings were obtained at room temperature (23°C).
Ca2+ currents of transiently transfected tsA201 cells
Whole-cell patch-clamp recordings were performed on transfected (GFP-
positive) tsA201 cells. Internal pipette solution contained (in mM): 134
CsCl, 10 EGTA, 1 EDTA, 10 HEPES pH 7.2 and 4 MgATP, with CsOH.
External solution contained (in mM): 2 CaCl2, 1 MgCl2, 10 HEPES pH 7.4
and 140 choline chloride, with CsOH. Some experiments were made using
BaCl2 (10 mM or 20 mM) instead of CaCl2 to amplify CaV current
amplitude. Cells were held at −100 mV to remove closed-state inactivation
(Thaler et al., 2004).
The test-pulse protocol consisted of voltage square pulses that were applied
every 10 s; CaV1.2: −100 mV to +10 mV for 15 ms, CaV2.2: −100 mV to
+10 mV 25ms, CaV1.3: −100 mV to −10 mV for 15 ms, and CaV3.2: −100
mV to −20 mV for 200 ms.
Ba2+ currents of primary neuronal cultures
Mouse neurons that had been cultured for 7–15 days were patched in
voltage-clamp whole-cell mode at a holding potential of -80 mV applying
squared test pulses to 0 mV for 20 ms every 10 s (Raingo et al., 2007).
Internal pipette solution contained (mM): 134 CsCl, 10 EGTA, 1 EDTA, 10
HEPES pH 7.2 and 4 MgATP, with CsOH. Neurons were bathed with high
[Na+] external solution containing (mM): 135 NaCl, 4.7 KCl, 1.2 MgCl2,
2.5 CaCl2, 10 HEPES pH 7.4 and 10 glucose, with NaOH. After getting the
whole cell configuration, CaV currents were recorded replacing the external
solution by a high [Ba2+] solution containing (mM): 10 BaCl2, 110 choline
chloride, 20 tetraethylammonium chloride, 1 MgCl2, 10 HEPES pH 7.4, 10
glucose and 0.001 tetrodotoxin (TTX; Sigma-Aldrich), with CsOH.
Imaging
In experiments presented in Figs 2–4, tsA201 cells had been co-transfected
with CaV2.2-GFP or CaV3.2-GFP, with or without its auxiliary subunits,
GHSR or pcDNA3.1 (+). At 48 or 24 h after transfection of CaV3.2-GFP or
CaV2.2-GFP, respectively, culture medium was replaced by 1 ml of 1 μg/ml
of membrane marker solution (CellMask orange plasma membrane stain;
Molecular probes) and cells were kept at 37°C for 1 min. After that, cells
were rinsed three times with 1× phosphate-buffered saline (PBS). To finish,
PBS was removed and a clean coverslip was placed over the cell layer.
Fluorescence photomicrographs were obtained using an optical
fluorescence microscope (Eclipse 50i; Nikon), equipped with B2A and
G2A filters and a camera (DS-Ri1; Nikon). Photomicrographs were
analyzed with FIJI free software, using the CellMask red signal to mark
out the plasma membrane and quantify green fluorescence intensity in both
the internal area (excluding plasmamembrane) and the total area of each cell
as integrated density. The fluorescence intensity corresponding to the
membrane (membrane fluorescence) was calculated as the difference
between the fluorescence corresponding to the total (total fluorescence) and
the internal area. Finally, the CaV2.2-GFP or CaV3.2-GFP membrane
fluorescence (in percent) was calculated for each cell, by using: (membrane
fluorescence/total fluorescence)×100.
In experiments presented in Figs 5–7 tsA201 cells had been plated on
glass coverslips treated previously with poly-L-lysine and laid over 12-well
plates. Cells were co-transfected 24 h later with CaVβ2a-eGFP or CaVβ3-
eGFP and with different plasmid combinations by using Lipofectamine.
Further 24 h later, cells were rinsed with 1×PBS. After that, cells were fixed
with 4% paraformaldehyde in PBS for 20 min, followed by a rinse with
1×PBS twice and were mounted on glass slides using VECTASHIELD®
mounting medium.
Confocal images were collected using a Zeiss LSM 800 confocal
microscope and ZEN software. Quantification of colocalization of CaVβ2a-
eGFP or CaVβ3-eGFP with the different intracellular compartment markers
was performed using Just another Colocalization Plugin (JaCoP) from FIJI,
to calculate Manders’ overlap coefficient for each marker (CaVβ-eGFP/
marker overlap).
Statistics
Datawere analyzed and visualized by using the OriginPro 8 (Origin-Lab) and
GraphPad Prism 5 (GraphPad Software, Inc.) software. We used the
Kolmogorov–Smirnov to test for conformity to a normal distribution;
variance homogeneity was examined by using Bartlett’s (normal distributed
data) and Brown-Forsythe′s (no normal distributed data) test. P values were
calculated from one- or two-sample t-tests (normally distributed data) or
Mann–Whitney test (no normally distributed data), and multiple comparison
oneway-ANOVAwith Tukey’s post hoc test (normal distributed data) or non-
parametric Kruskal–Wallis test with Dunn’s post-test (no normal distributed
data). P values were calculated and included in the figures. Specific statistical
test used is indicated for each data set. Data were expressed as mean±s.e.m.
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Strasburger, C. J., Bidlingmaier, M., Esterman, M., Heiman, M. L. et al. (2003).
The distribution and mechanism of action of ghrelin in the CNS demonstrates a
novel hypothalamic circuit regulating energy homeostasis. Neuron 37, 649-661.
Chien, A. J., Zhao, X., Shirokov, R. E., Puri, T. S., Chang, C. F., Sun, D., Rios, E.
and Hosey, M. M. (1995). Roles of a membrane-localized beta subunit in the
formation and targeting of functional L-type Ca2+ channels. J. Biol. Chem. 270,
30036-30044.
Chien, A. J., Carr, K. M., Shirokov, R. E., Rios, E. and Hosey, M. M. (1996).
Identification of palmitoylation sites within the L-type calcium channel beta2a
subunit and effects on channel function. J. Biol. Chem. 271, 26465-26468.
Chien, A. J., Gao, T., Perez-Reyes, E. and Hosey, M. M. (1998). Membrane
targeting of L-type calcium channels. Role of palmitoylation in the subcellular
localization of the beta2a subunit. J. Biol. Chem. 273, 23590-23597.
De Waard, M., Pragnell, M. and Campbell, K. P. (1994). Ca2+ channel regulation
by a conserved beta subunit domain. Neuron 13, 495-503.
Dolmetsch, R. E., Pajvani, U., Fife, K., Spotts, J. M. andGreenberg, M. E. (2001).
Signaling to the nucleus by an L-type calcium channel-calmodulin complex
through the MAP kinase pathway. Science 294, 333-339.
Dolphin, A. C. (2003). Beta subunits of voltage-gated calcium channels.
J. Bioenerg. Biomembr. 35, 599-620.
Dolphin, A. C. (2012). Calcium channel auxiliary alpha2delta and beta subunits:
trafficking and one step beyond. Nat. Rev. Neurosci. 13, 542-555.
Dolphin, A. C. (2016). Voltage-gated calcium channels and their auxiliary subunits:
physiology and pathophysiology and pharmacology. J. Physiol. 594, 5369-5390.
Dolphin, A. C., Wyatt, C. N., Richards, J., Beattie, R. E., Craig, P., Lee, J.-H.,
Cribbs, L. L., Volsen, S. G. and Perez-Reyes, E. (1999). The effect of alpha2-
delta and other accessory subunits on expression and properties of the calcium
channel alpha1G. J. Physiol. 519, 35-45.
Dubel, S. J., Altier, C., Chaumont, S., Lory, P., Bourinet, E. and Nargeot, J.
(2004). Plasma membrane expression of T-type calcium channel alpha(1)
subunits is modulated by high voltage-activated auxiliary subunits. J. Biol.
Chem. 279, 29263-29269.
Dunlap, K., Luebke, J. I. and Turner, T. J. (1995). Exocytotic Ca2+ channels in
mammalian central neurons. Trends Neurosci. 18, 89-98.
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